Search results
Showing 766 to 780 of 1561 results for do not do recommendations
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma (TA894)
Evidence-based recommendations on axicabtagene ciloleucel (Yescarta) for relapsed or refractory follicular lymphoma in adults.
Evidence-based recommendations on lenalidomide (Revlimid) for maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma in adults.
Recommendation ID CG137/5 Question AEDs and pregnancy: What is the malformation rate and longer term neurodevelopmental outcome of...
the environment. We're hoping to find a proportionate and pragmatic way to do this, bearing in mind that data and methods in this can...
Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years (TA213)
Evidence-based recommendations on aripiprazole for treating schizophrenia in young people aged 15 to 17.
Evidence-based recommendations on new generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners.
Recommendation ID NG68/5 Question Can GP practices deliver effective and cost effective condom schemes to reduce STIs?: -Can condom...
Recommendation ID NG70/3 Question Clean air zones:- How do different elements of a clean air zone interact to improve air...
Recommendation ID NG43/6 Question Supporting young people to manage their conditions:- What is the relationship between transition and
Recommendation ID CG126/1 Question Adding a newer anti-anginal drug to a calcium channel blocker:- What is the clinical and cost...
Recommendation ID NG157/11 Question Do the direct anterior, direct superior and supercapsular percutaneously assisted...
Recommendation ID NG50/2 Question Treating small oesophageal varices:- Do non-selective beta-blockers improve survival and...
Recommendation ID CG137/1 Question Newly diagnosed seizures (focal and generalised) – monotherapy: How do the newer AEDs...
Evidence-based recommendations on leniolisib (Joenja) for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over.
Inotersen for treating hereditary transthyretin amyloidosis (HST9)
Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis.